Compositions and methods for delivering syntaxin-binding protein-1
TW202635893APending Publication Date: 2026-09-01NEUROCRINE BIOSCIENCES INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114141894
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-10-30
- Filing Date
- 2025-10-29
- Publication Date
- 2026-09-01
Smart Images

Figure TWG2TA001074532_001 
Figure TWG2TA001074532_002 
Figure TWG2TA001074532_003
Abstract
The disclosure relates to polynucleotides, e.g., viral genomes, encoding syntaxin-binding protein-1 (STXBP1), vectors, e.g., adeno-associated virus (AAV) particles, comprising said polynucleotides, compositions comprising said polynucleotides or vectors, and methods of making or delivering to a cell or subject. The polynucleotides, vectors, compositions, and methods of the present disclosure are useful for the treatment of subjects who have, have been diagnosed with having, or are at risk of having a STXBP1-related disorder, e.g., STXBP1 Developmental and Epileptic Encephalopathy (DEE) and / or other STXBP1-related disorders, or at least one symptom thereof.
Need to check novelty before this filing date? Find Prior Art